Skip to content

Clinical study of Cui's

Clinical study of Cui's

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006025
Enrollment
Unknown
Registered
2022-05-21
Start date
2022-05-09
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthropathy

Interventions

Test group:Basic treatment+Fumigation of "soft wound lotion"
Control group:Basic treatment + oral celecoxib capsule

Sponsors

Beijing Gulou Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Those who meet the diagnostic criteria of traditional Chinese and Western medicine for knee osteoarthritis and KL grade I-III; ? Age = 50 years old; ? Patients who have received other treatment but have gone through a washout period of more than 7 days; ? Agree to participate in this study and voluntarily sign the informed consent form, which can cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: ? Secondary osteoarthritis, such as rheumatoid arthritis, ankylosing spondylitis, gouty arthritis, etc; ? Severe allergic constitution; ? Poor general condition, complicated with serious digestive tract, heart, brain, vascular, liver and kidney diseases; Or combined with other diseases that may affect the knee, such as bone tumors; ? Poor autonomy, confused language and thinking, and the evaluation can not reflect the objective actual situation.

Design outcomes

Primary

MeasureTime frame
Total effective rate;

Secondary

MeasureTime frame
Quantitative score of TCM Syndrome;VAS;Western Ontario and McMaster University Osteoarthritis Index score;

Countries

China

Contacts

Public ContactJiangmengjia
glzyjmj@163.com18211017285

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026